12:00 AM
Jun 04, 2012
 |  BC Week In Review  |  Company News  |  Deals

Dyax, Bayer deal

Bayer's Bayer Pharma AG licensed Dyax's antibody phage display technology to develop and commercialize antibodies identified using...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >